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ABSTRACT
OBJECTIVES
To estimate small for gestational age birth prevalence 
and attributable neonatal mortality in low and middle 
income countries with the INTERGROWTH-21st birth 
weight standard.
DESIGN
Secondary analysis of data from the Child Health 
Epidemiology Reference Group (CHERG), including 
14 birth cohorts with gestational age, birth weight, 
and neonatal follow-up. Small for gestational 
age was defined as infants weighing less than 
the 10th centile birth weight for gestational age 
and sex with the multiethnic, INTERGROWTH-21st 
birth weight standard. Prevalence of small for 
gestational age and neonatal mortality risk ratios 
were calculated and pooled among these datasets 
at the regional level. With available national level 
data, prevalence of small for gestational age and 
population attributable fractions of neonatal mortality 
attributable to small for gestational age were 
estimated.
SETTING
CHERG birth cohorts from 14 population based sites in 
low and middle income countries.
MAIN OUTCOME MEASURES
In low and middle income countries in the year 2012, 
the number and proportion of infants born small for 
gestational age; number and proportion of neonatal 
deaths attributable to small for gestational age; the 
number and proportion of neonatal deaths that could 
be prevented by reducing the prevalence of small for 
gestational age to 10%.
RESULTS
In 2012, an estimated 23.3 million infants 
(uncertainty range 17.6 to 31.9; 19.3% of live births) 
were born small for gestational age in low and middle 
income countries. Among these, 11.2 million (0.8 to 
15.8) were term and not low birth weight (≥2500 g), 
10.7 million (7.6 to 15.0) were term and low birth 
weight (<2500 g) and 1.5 million (0.9 to 2.6) were 
preterm. In low and middle income countries, an 
estimated 606 500 (495 000 to 773 000) neonatal 
deaths were attributable to infants born small for 
gestational age, 21.9% of all neonatal deaths. 
The largest burden was in South Asia, where the 
prevalence was the highest (34%); about 26% of 
neonatal deaths were attributable to infants born 
small for gestational age. Reduction of the prevalence 
of small for gestational age from 19.3% to 10.0% in 
these countries could reduce neonatal deaths by 9.2% 
(254 600 neonatal deaths; 164 800 to 449 700).
CONCLUSIONS
In low and middle income countries, about one in 
five infants are born small for gestational age, and 
one in four neonatal deaths are among such infants. 
Increased efforts are required to improve the quality 
of care for and survival of these high risk infants in low 
and middle income countries
Introduction
Neonatal conditions are responsible for an increasing 
proportion of deaths of children aged under 5 and 
are a key focus of the post-2015 development agenda 
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WhAT IS AlReAdy knoWn on ThIS TopIC
Infants born small for gestational age are at risk for neonatal mortality
Small for gestational age is highly prevalent in low and middle income countries, 
particularly in South Asia
Prior global estimates of small for gestational age have used the US 1991 live 
birth data as the birth weight reference
WhAT ThIS STudy AddS
An estimated 23.3 million infants (uncertainty range 17.6 million to 31.9 
million; 19.3% of live births) were born small for gestational age in low and 
middle income countries in 2012, with the INTERGROWTH-21st standard, the first 
international, multiethnic birth weight standard, as reference
In low and middle income countries in 2012, 606 500 (21.9%) (495 000 to 
773 000) neonatal deaths were attributable to small for gestational age
The highest burden was in South Asia, where the prevalence of small for 
gestational age was the highest (34%) and the population attributable fraction of 
attributable neonatal deaths was 26%
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and the Every Newborn Action Plan.1 2 Preterm birth, 
intrapartum related events, and neonatal infections 
are the main direct causes of neonatal mortality.3 
Other risk factors for mortality, however, such as 
intrauterine growth restriction, are not classified as 
underlying or immediate causes of death according 
to ICD (international classification of diseases) rules.4 
To most effectively target interventions to accelerate 
reductions in neonatal mortality, it is critical to 
quantify the attributable burden of mortality from 
major neonatal risk factors that are not classified as 
underlying or direct causes of death.
Infants born small for gestational age are defined 
by the WHO Expert Committee5 and the American 
College of Obstetrics and Gynecology6 as those 
weighing below the 10th centile of birth weight by 
sex for a specific completed gestational age of a given 
reference population. It is commonly used as a proxy 
for intrauterine growth restriction and, in settings 
with a high prevalence of small for gestational age, is 
more likely to be because of fetal intrauterine growth 
restriction.7
Infants born small for gestational age carry a 
considerably higher risk of mortality and morbidity 
in the neonatal period and beyond. They are more 
likely to have neonatal infections, perinatal respiratory 
depression, jaundice, polycythemia, hypoglycemia, 
poor feeding, and hypothermia. These morbidities 
in turn place them at higher risk of death. In a 
pooled analysis by the Child Health Epidemiology 
Reference Group (CHERG), small for gestational age 
was associated with increased risk of neonatal and 
postneonatal mortality (risk ratio 1.83 (95% confidence 
interval 1.34 to 2.50) for neonatal mortality; 1.90 (1.32 
to 2.73) for postneonatal infant mortality) compared 
with infants born at an appropriate size for gestational 
age (≥10% birth weight for gestational age). The risk 
was even higher among those born both preterm 
and small for gestational age.8 Infants born small for 
gestational age also have an increased risk of delayed 
neurodevelopment and poor linear growth,9 with 
those born term and preterm being 2.4 and 4.5 times, 
respectively, more likely to be stunted in childhood 
than term babies infants born appropriate size for 
gestational age.10 Modifiable risk factors for small for 
gestational age include poor maternal nutrition,11 
maternal infections and other morbidities,12 young 
maternal age,13 and short birth spacing.14 Intrauterine 
programming and genetic modulation have also been 
postulated as mechanisms resulting in small for 
gestational age and increased risk of morbidity later in 
life, predisposing those infants to higher risk of insulin 
resistance, obesity, dyslipidaemia, and hypertension 
in adulthood.15 16
Epidemiologic estimates of small for gestational age 
vary substantially based on the reference population.17 
The use of a single universal growth standard versus 
local/national ethnic specific growth references is still 
heavily debated.18 While genetic potential for growth 
might differ across populations,19 20 this contribution 
is believed by some to play a smaller role in low and 
middle income countries on infant size at birth, 
compared with the impact of maternal undernutrition 
and pregnancy morbidity.5 As part of the CHERG, we 
investigated the global burden of infants born small for 
gestational age, the contribution of pregnancy risks, 
and the potential impact of preventive interventions to 
deal with risk factors to optimize fetal growth globally. 
The INTERGROWTH-21st project21 (henceforth referred 
to as Intergrowth) established the first international, 
multiethnic standard including well dated pregnancies 
from eight geographically defined populations, and 
enables a common single standard to describe optimal 
and aspirational fetal growth around the world.21 The 
Intergrowth study found that among healthy pregnant 
women with adequate nutrition, fetal growth was 
comparable across different populations around the 
world.22 Therefore, Intergrowth was chosen as the 
standard for this analysis in a prescriptive sense, to 
describe the global burden of suboptimal fetal growth. 
Choice of unselected, local, national population 
references would simply describe fetal growth with 
current rates of exposure to undernutrition and 
pregnancy morbidities in low and middle income 
countries, and would not allow us to target the 
optimization of fetal growth globally from a population 
health perspective.
The population attributable fraction reflects the 
burden of disease attributable to a causal risk factor 
if it were reduced from the current exposure level to 
a theoretical minimum counterfactual distribution. 
This allows the estimation of the potential reduction in 
mortality if the exposures were eliminated or, in other 
words, the attribution of indirect deaths caused by 
given risk factors. We estimated the number of infants 
born small for gestational age in low and middle income 
countries in 2012 using the new Intergrowth standard, 
the number of neonatal deaths attributable to being 
small for gestational age in these countries, and the 
number of neonatal deaths that could be prevented by 
reducing the prevalence of small for gestational age to 
a theoretical minimum level of 10% in these countries. 
We also compared our results to previously published 
estimates of prevalence of small for gestational aged 
derived from a US birth weight reference.23
Methods
We have built on prior analyses of the CHERG on 
the burden and risk of small for gestational age and 
preterm birth in low and middle income countries.82425 
An investigator group (CHERG SGA-Preterm Birth 
Working Group) was established in 2009 to conduct 
a set of analyses related to small for gestational age 
and preterm birth. To identify datasets to include in 
the analyses, we reviewed Medline, WHO regional 
databases (African Index Medicus, LILAS, EMRO), 
manuscript bibliographies, and grey literature to 
identify cohorts from low and middle income countries 
with information on gestational age and birth weight 
and that systematically recorded vital status until 28 
days of life. We included datasets that were population 
based, representing most deliveries from certain 
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geographic or catchment areas, whether home or 
facility based. We excluded datasets with more than 
25% missing data on birth weight, gestational age, 
or neonatal follow-up; measured weight only after 
72 hours of life; did not have systematic follow-up of 
vital status in the first month of life; or had imprecise 
gestational age data (determined in whole months 
or deemed “inaccurate” by study investigators). Full 
details on the literature review process and selection 
of datasets have been previously published by our 
research group.8 Principal investigators were requested 
to either individually conduct analyses or to share their 
data with the working group. We included 14 birth 
cohorts in this analysis.26-39 The original studies were 
from prospective studies, including longitudinal birth 
cohorts (n=4) and pregnancy/neonatal intervention 
trials (n=10). The original datasets and study 
descriptions are shown in appendix 1. Most datasets 
were from 2000 onwards, with three studies from 
the 1990s. This analysis excludes datasets used in 
previous CHERG analyses that were from before 1990 
or were not directly available to the analysts for this 
study.8
In previously published analyses, we estimated the 
prevalence of small for gestational age and preterm 
birth in low and middle income countries for the year 
2010, using the US 1991 birth population as a reference 
(US National Center for Health Statistics, n=3 808 689 
live births in 1991)25 and the associations of small for 
gestational age (defined using this US reference) and 
preterm birth with both neonatal and postneonatal 
infant mortality, respectively.8 In the current analyses, 
we estimate the numbers of small for gestational age 
births and neonatal deaths attributable to this in 
low and middle income countries in 2012 using the 
international Intergrowth birth weight standard to 
define small for gestational age.
Exposure definitions
Small for gestational age was defined as a birth weight 
less than the 10th centile for a specific completed 
gestational age by sex, using the Intergrowth 
standard.21 40 The Intergrowth cutoffs were taken 
from two publications, the first for gestational age 
≥33 weeks21 and the second for <33 completed weeks 
of gestation.40 In the CHERG cohorts, gestational age 
was estimated with ultrasonography or best obstetric 
estimate including ultrasonography in six studies, 
date of last menstrual period alone for five studies, 
postnatal clinical exam (Ballard and Capurro) for two 
studies, and a combination in one study (see appendix 
1 for more details). We also compared these results 
with small for gestational age defined by the 1991 US 
national population reference, which was used in the 
original CHERG analysis.23 Preterm birth was defined 
as gestational age of <37 completed weeks. Low 
birth weight was defined as birth weight of <2500  g. 
We created four mutually exclusive exposures: term 
appropriate for gestational age (as reference), term 
small for gestational age, preterm appropriate for 
gestational age, and preterm small for gestational 
age (fig 1). Term small for gestational age was further 
separated into low birth weight and not low birth 
weight to differentiate the mortality burden associated 
with smaller and larger term small for gestational age 
infants.
Population distribution of small for gestational age 
and preterm birth
CHERG previously estimated national and regional 
prevalences of preterm birth24 and small for 
gestational age for 201025 and 201241 using the 
US 1991 population birth weight reference.23 To 
estimate prevalence of small for gestational age 
with the Intergrowth standard,21 we calculated the 
percentage change of term and preterm small for 
gestational age births in the 14 CHERG datasets, 
comparing the US population reference with the 
Intergrowth standard. We performed meta-analysis 
using random effects to pool the percentage change 
at the regional level (Asia, Africa, Americas) and 
multiplied the region specific adjustment factor by 
the previously estimated national level prevalences 
of small for gestational age from 2012 (see appendix 
2).42 We performed a similar process to calculate the 
proportion of term small for gestational age infants 
with low birth weight.
Risk ratios for neonatal mortality
Mortality was analyzed in the neonatal (birth-28 days 
of life) period. For each dataset, we calculated risk 
ratios for neonatal mortality (death within first 28 days 
of life) for preterm birth and small for gestational age, 
classified using the US 1991 reference and Intergrowth 
standard.8 We pooled risk ratios for neonatal mortality 
for categories of small for gestational age separately 
for each reference/standard, at the regional level, 
with random effects meta-analysis to calculate 
DerSimonian-Laird pooled risk ratios and 95% 
confidence intervals (see appendix 3).
Neonatal deaths attributable to small for 
gestational age birth
We used neonatal mortality rates from the Inter-Agency 
Group for Child Mortality Estimation43 and live births 
from the UN Population Division44 for the year 2012.
<37 weeks
(preterm)
≥37 weeks
(term)
37
weeks
<2500 g
LBW
2500 g
≥2500 g
not LBW Preterm AGA,not LBW
Preterm
AGA, LBW
Preterm
SGA, LBW
Term AGA,
not LBW
Term SGA,
not LBW
Term SGA,
LBW
10th
 cent
ile
Fig 1 | Combinations of exposure categories of 
preterm birth, small for gestational age (SGA), and 
low birth weight (LBW, <2500 g). AGA=appropriate for 
gestational age
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Population attributable fraction, the “proportion 
of cases for an outcome of interest that can be 
attributed to a given risk factor,” is defined as the 
(incidence rate in population−incidence rate in 
unexposed)/incidence rate in the total population.45 
In this paper, we estimated the neonatal deaths that 
would result if the causally related risk factor (in this 
case, small for gestational age) was reduced from 
its current exposure level to a theoretical minimum 
counterfactual distribution. Using established 
methods of comparative risk assessment46 used for 
the global burden of disease,47 we estimated the total 
number of neonatal deaths that were attributable to 
small for gestational age, as well as the number of such 
deaths that would be prevented if the prevalence of 
small for gestational age was reduced to a theoretical 
minimum level of 10% in all low and middle income 
countries, the distribution expected among low risk 
mothers, similar to the Intergrowth population. For 
the co-occurrence of preterm and small for gestational 
age, the theoretical minimum risk level of mortality 
was that of preterm appropriate for gestational age 
infants to attribute the deaths related only to small for 
gestational age. The population attributable fraction 
for multiple category exposures can be estimated by 
the equation for potential impact fraction (fig 2).45 48 49 
We calculated population attributable fractions and 
number of neonatal deaths averted at the national level 
and then aggregated by UN-Millennium Development 
Goal regions for 138 low and middle income countries.
Population attributable fraction uncertainty 
estimates
Methods to estimate uncertainty ranges have been 
developed by the CHERG by using a bootstrap 
approach as opposed to jackknife procedures to allow 
more plausible uncertainty ranges.3 These methods are 
described in detail in appendix 4.
Patient involvement
This study was a secondary data analysis of existing 
datasets, which did not involve new direct contact with 
patients. For all parts of these secondary data analyses, 
patients, caregivers, and lay people were not involved in 
the development of the research question, study design, 
or outcome measures, nor the interpretation or writing up 
of the results. Some of the original studies contributing 
to this analysis included recruitment of participants by 
lay community health workers. Data from this study will 
be published and made publicly available. Investigators 
might share the results with local ministries of health, 
patients (including original study participants), and 
relevant medical organizations in the respective countries 
where the original studies were conducted.
Results
Small for gestational age live births in low and 
middle income countries in 2012
Table 1 and figure 3 show the estimated numbers and 
prevalence of small for gestational age among live 
births for the year 2012, defined by the Intergrowth 
standard. National level estimates are available in 
appendix 5. The regional numbers are compared with 
estimates using the US 1991 population reference in 
appendix 6. In low and middle income countries, 23.3 
million infants were born small for gestational age as 
Table 1 | Numbers of 1000s of infants born small for gestational age (SGA) in 2012 with INTERGROWTH-21st birth weight standard in low and middle 
income countries in regions covered by UN Millennium Development Goals
No of live  
births (1000s)
No (UR*) of term SGA (1000s) No (UR*) of preterm 
SGA (1000s
Total No (UR*) of SGA 
(1000s)
% prevalence (UR*) 
SGANot low birth weight Low birth weight†
Caucasus/Central Asia 1774.3 87.0 (49.2 to 148.6) 89.1 (50.8 to 
152.0)
19.4 (9.4 to 41.6) 195.5 (121.1 to 
314.1)
11.0 (6.2 to 19.3)
Eastern Asia 19 097.2 387.4 (170.4 to 
788.5)
396.8 (180.0 to 
799.2)
165.4 (82.6 to 
320.1)
949.5 (536.7 to 
1735.4)
5.0 (2.4 to 10.4)
Latin America/Caribbean 10 833.3 516.3 (406.5 to 
1157.1)
303.2 (241.1 to 
687.5)
110.8 (83.3 to 
243.5)
930.3 (793.2 to 
2019.5)
8.6 (6.7 to 19.3)
Northern Africa 3989.8 120.9 (59.8 to 
233.0)
102.6 (49.8 to 
200.6)
24.6 (10.3 to 53.7) 248.2 (138.9 to 
455.7)
6.2 (3.0 to 12.2)
Oceania 266.4 20.0 (12.1 to 31.6) 20.4 (12.9 to 32.4) 2.3 (1.0 to 6.3) 42.7 (28.1 to 66.0) 16.0 (9.8 to 26.4)
South East Asia 9691.1 941.7 (587.6 to 
1448.6)
964.6 (609.8 to 
1499.1)
183.5 (88.0 to 
386.4)
2089.9 (1403.2 to 
3157.7)
21.6 (14.2 to 37.7)
South Asia 36 625.8 5908.5 (3849.1 to 
8672.5)
6052.1 (3974.6 to 
8954.2)
577.1 (291.6 to 
1162.3)
12 537.7 (8651.8 to 
18 100.0)
34.2 (22.2 to 51.3)
Sub-Saharan Africa 33 727.5 2829.5 (1522.8 to 
5105.4)
2400.6 (1253.1 to 
4297.7)
345.0 (158.9 to 
716.8)
5575.2 (3276.3 to 
9277.2)
16.5 (8.7 to 25.1)
Western Asia 4 844.9 346.0 (213.3 to 
538.3)
354.4 (224.7 to 
558.5)
56.2 (28.2 to 118.2) 756.6 (504.6 to 
1154.3)
15.6 (9.6 to 25.1)
Total 120 850.2 11 157.4 (8195.4 to 
15 798.3)
10 683.9 (7616.9 to 
15 017.0)
1484.3 (902.2 to 
2628.7)
23 325.6 (17 599.3 
to 31 914.8)
19.3 (11.9 to 32.1)
*Uncertainty range (UR) derived with bootstrap approach (see appendix 4).
†≤2500 g.
=
Σni=1
PAF
–Pi*RRi
Σni=1 Pi*RRi
Σni=1 Pi*RRi'
Fig 2 | Equation for population attributable fraction (PAF). 
Pi=proportion of population at exposure level i, current 
exposure; P’i = proportion of population at exposure 
level i, counterfactual or ideal level of exposure; RR= risk 
ratio at exposure level i; n=number of exposure levels
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defined by the Intergrowth standard, with a prevalence 
of 19.3%. The highest number and prevalence of such 
births was in South Asia, at 12.5 million (34.2%) 
infants. Most (62.7%) small for gestational age births 
occurred in South or South East Asia. An estimated 5.6 
million infants born in sub-Saharan Africa were small 
for gestational age (prevalence 16.5%).
The total number of estimated small for gestational 
age births was 27% lower when we used the Intergrowth 
standard compared with the US population reference 
(appendix 6). The largest absolute difference was in 
the number of term small for gestational age infants 
who weighed above 2500 g (18.8 million by US 
1991 reference compared with 11.2 million with the 
Intergrowth standard, 41% reduction). The greatest 
relative reduction was among the preterm infants 
(47% lower with Intergrowth).
Neonatal deaths attributable to small for 
gestational age in 2012
An estimated 606 500 neonatal deaths (21.9% of 
neonatal deaths) in low and middle income countries 
were attributable to being born small for gestational 
age in 2012, as defined with the Intergrowth standard 
(table 2, fig 4). In total, 410 600 were among term 
small for gestational age infants, the majority weighing 
<2500 g, and an estimated 195 900 neonatal deaths 
among preterm small for gestational age infants. The 
largest number of neonatal deaths attributable to 
small for gestational age was in South Asia, where the 
prevalence of small for gestational age was highest 
(at 34%) and 26% of neonatal deaths were attributed 
to this risk factor. About half of the neonatal deaths 
attributable to small for gestational age (322 700) 
occurred in South or South East Asia. National level 
estimates are shown in appendix 7.
Compared with the US 1991 birth population, the 
total number of neonatal deaths attributable to small 
for gestational age with the Intergrowth standard 
was about 21% lower (appendix 8). There was also 
a relatively large reduction (48%) in the number of 
neonatal deaths attributed to small for gestational 
age in term infants who weighed ≥2500 g as well as 
preterm small for gestational age (42%) infants with 
the Intergrowth classification, in large part because of 
the lower prevalence of births in these groups with the 
Intergrowth standard.
Table 3 lists the 10 countries with the largest 
numbers of estimated deaths in infants born small for 
gestational age in 2012. The highest number was in 
India, where 9.1 million such infants (36.5% of live 
births) were born in 2012, with 202 300 attributable 
neonatal deaths. Pakistan and Nigeria also had high 
numbers of both infants born small for gestational 
age (1.7 million in Pakistan, 1.1 million in Nigeria)25 
and attributable neonatal deaths (53 700 and 51 800, 
respectively). The highest proportions of neonatal 
deaths that were attributable to small for gestational 
age were in Sudan (28.7%), Pakistan (26.5%), and 
India (26.0%).
-In an international, multiethnic setting of optimal 
nutrition and health in pregnancy, we would expect 
10% of infants to be born small for gestational age. 
Reduction in the prevalence of small for gestational 
Table 2 | Numbers of 1000s of neonatal deaths in 2012 attributable to term and preterm infants born small for gestational age (SGA) in low and middle 
income countries in regions covered by UN Millennium Development Goals
No of live  
births (1000s)*
No (UR*) of neonatal deaths (1000s)
Population  
attributable  
fraction† (UR*)
Total  
(1000s)
Term SGA
Preterm SGA All SGA
Not low birth  
weight Low birth weight
Caucasus/Central Asia 1774.3 26.5 — 1.5 (0.9 to 2.5) 2.3 (1.2 to 4.3) 3.8 (2.6 to 5.8) 14.3 (9.9 to 22.0)
Eastern Asia 19 097.2 158.9 — 4.2 (1.9 to 8.3) 11.9 (6.3 to 21.5) 16.1 (10.3 to 25.9) 10.1 (6.5 to 16.3)
Latin America/Caribbean 10 833.3 105.9 — 8.6 (6.5 to 17.5) 18.7 (13.1 to 29.6) 27.3 (24.8 to 40.4) 25.8 (23.4 to 38.1)
Northern Africa 3989.8 50.6 1.6 (0.8 to 2.9) 2.7 (1.4 to 5.0) 0.9 (0.4 to 1.8) 5.2 (3.1 to 8.8) 10.3 (6.1 to 17.3)
Oceania 266.4 5.7 — 0.5 (0.3 to 0.8) 0.4 (0.2 to 0.9) 0.9 (0.7 to 1.4) 15.8 (11.4 to 24.0)
South East Asia 9691.1 143.9 — 14.5 (9.2 to 21.9) 18.5 (9.5 to 33.4) 33.0 (24.4 to 47.3) 22.9 (17.0 to 32.9)
South Asia 36 625.8 1127.3 — 175.8 (123.0 to 248.1) 113.9 (63.2 to 204.4) 289.7 (227.6 to 383.1) 25.7 (20.2 to 34.0)
Sub-Saharan Africa 33 727.5 1090.2 72.2 (41.7 to 
118.3)
123.2 (68.7 to 198.5) 23.9 (11.4 to 47.3) 219.3 (143.3 to 325.4) 20.1 (13.1 to 29.8)
Western Asia 4844.9 63.4 — 5.6 (3.6 to 8.4) 5.4 (2.8 to 10.0) 11.0 (8.2 to 15.5) 17.4 (13.0 to 24.5)
Total 120 850.2 2772.4 73.8 (42.5  
to 120.7)
336.8 (250.7 to 453.8) 195.9 (123.0 to 325.0) 606.5 (494.8 to 772.9) 21.9 (17.8 to 27.9)
*Uncertainty range (UR) derived with bootstrap approach (see appendix 4).
†%of neonatal deaths attributable to SGA.
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Fig 3 | Prevalence of infants born small for gestational 
age (SGA) among live births in low and middle income 
countries in 2012, by UN-MDG region. LBW=low birth 
weight (<2500 g)
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age from 19.3% to 10.0% in low and middle income 
countries could reduce total neonatal deaths by 
9.2% (254 600 neonatal deaths; uncertainty range 
164 800 to 449 700, appendix 9). The highest impact 
on newborn lives saved would be seen in India 
(n=109 000), Pakistan (27 000), Nigeria (21 000), and 
Ethiopia (21 000).
discussion
Our study reports the first global estimates of the 
burden of small for gestational age among live births 
and the contribution of small for gestational age as a 
risk factor for (or indirect cause of) neonatal mortality 
with the Intergrowth standard, for the year 2012. We 
estimate that in low and middle income countries, 23.3 
million infants (19.3%) were born small for gestational 
age (11.2 million term and not low birth weight, 
10.7 million term and low birth weight, 1.5 million 
preterm), and about 606 500 neonatal deaths (21.9%) 
were attributable to being born small for gestational 
age. The highest burden was in South Asia, where up 
to 34% of infants might be born small for gestational 
age and 26% of neonatal deaths were attributable to 
small for gestational age. If the prevalence of small 
for gestational age were reduced to a level of 10% (the 
prevalence that would be expected in an international 
population of optimal nutrition and health in 
pregnancy) in all low and middle income countries, an 
estimated 9.2% of neonatal deaths (n=254 600) could 
be averted.
In this analysis, we used the Intergrowth standard 
to classify small for gestational age infants2150 because 
our primary objective was to determine the global 
burden of suboptimal fetal growth, aspiring to a 
scenario where all mothers’ nutritional and health 
needs are met. There is still extensive debate, however, 
about the use of a single universal standard versus 
ethnic specific or customized fetal growth standards, 
and whether Intergrowth’s population was too 
selective. While genetic potential for growth can differ 
across populations, we think that in low and middle 
income countries these differences play a smaller 
role compared with the much larger variability in 
maternal nutritional status and health in pregnancy.5 
Intergrowth showed in their cohort (n=20 486) that 
fetuses in healthy well nourished pregnant women 
from eight different geographic regions grew similarly 
across diverse geographic regions.21 22 Furthermore, 
the neonatal birth weights of Intergrowth are 
comparable with the WHO Child Growth Standards for 
term neonates.21 We therefore chose the Intergrowth 
standard as the most appropriate prescriptive standard 
to describe the global burden of suboptimal fetal 
growth and the population impact of public health 
interventions to deal with this.
There is also an argument, however, for the use 
of ethnic specific fetal growth references. In the 
Netherlands, Visser and colleagues published 
population birth weight reference curves and showed 
that Dutch Hindustani babies were systematically of 
lower birth weight than other ethnic groups, up to 300 
g at certain gestational weeks.51 Two recent studies 
that used longitudinal ultrasound data in populations 
at low obstetric risk have shown ethnic differences in 
fetal growth, as measured by ultrasound estimated 
fetal weight.1920 The NICHD Fetal Growth study in the 
US included women at low obstetric risk and found 
significant differences in estimated fetal weight after 
20 weeks, with lower weight among Hispanic, Asian, 
and Black women compared with non-Hispanic white 
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Fig 4 | Proportion of total neonatal deaths attributable 
to infants born small for gestational age (SGA) in low 
and middle income countries in 2012 by UN-MDG region. 
LBW=low birth weight (<2500 g)
Table 3 | Ten countries with highest burden of neonatal mortality attributable to infants born small for gestational age (SGA)
No of live  
births (1000s)
Neonatal mortality  
rate* 2012
Preterm birth  
rate 2012 (%)
Prevalence of  
SGA (%)
No of attributable neonatal deaths (1000s) Population attributable  
fraction†Term SGA Preterm SGA All SGA
1 India 25 000 30.9 13.1 36.5 126.3 76 202.3 26.0
2 Pakistan 4800 42.2 15.8 36.0 30.8 22.9 53.7 26.5
3 Nigeria 6800 39.2 12.2 15.6 45.8 6.0 51.8 19.4
4 Bangladesh 3100 24.4 14.1 30.5 10.3 8.1 18.3 24.2
5 China 19 000 8.5 6.9 4.6 3.8 11.3 15.1 9.6
6 Indonesia 4800 15.0 15.6 18.0 5.7 8.8 14.5 19.9
7 Ethiopia 3000 29.0 10.2 21.4 20.8 1.6 22.4 25.5
8 Philippines 2300 14.0 14.9 25.6 3.6 3.7 7.3 22.7
9 DR Congo 2700 43.5 12.0 14.5 19.0 2.6 21.7 18.3
10 Sudan 1200 28.6 13.4 28.0 9.3 0.7 10.0 28.7
*Per 1000 live births.
†% of neonatal deaths attributable to SGA.
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women.19 The WHO multinational longitudinal study 
of ultrasound biometric measurements and estimated 
fetal weight included low risk pregnancies from 10 
countries, and reported significant differences in 
estimated fetal weight and birth weight between 
countries, with the lowest median birth weight in 
India.20 There are differences that could explain 
the discrepant findings between these studies and 
Intergrowth. Intergrowth had stricter nutritional 
criteria such as excluding mothers with height <153 cm, 
whereas the NICHD and WHO did not exclude mothers 
based on height. These latter studies were also of 
smaller sample size, were primarily based on estimated 
fetal weight by ultrasound, and have not yet published 
birth weight standards. The use of individual level, 
customized birth weight standards that account for 
ethnicity and maternal characteristics (height, weight, 
parity) more accurately identified small for gestational 
age infants at risk of stillbirth or neonatal mortality in 
New Zealand.52 The application of customized charts, 
however, is not possible for population level estimates, 
and such charts also include targetable risk factors for 
small for gestational age in their growth predictions 
(for example, maternal undernutrition).
National or ethnic references are also often 
challenged by the fact that they are developed from 
the local population and are unselected, including 
all the pregnancies and existing morbidities of a local 
population/catchment area. Though these describe 
local patterns of fetal growth, they also include 
pregnancies that are affected by undernutrition and 
morbidities such as infections (for example, malaria, 
syphilis) and hypertension. Therefore, small for 
gestational age simply defines the lowest 10% of these 
populations, but this classification does not identify 
the many more newborns affected by poor growth. 
Use of local curves results in a predefined prevalence 
of small for gestational age close to 10%, irrespective 
of a population’s health and nutritional status. 
For example, with the Bhatia reference that was 
developed for single liveborn infants in India,53 the 
estimated number of infants born small for gestational 
age in South Asia for 2012 would be reduced to 3.8 
million infants (10.5% of live births) in the year 
2012,17 compared with 12.5 million (34%) with the 
Intergrowth standard.
Intergrowth’s 10th centile birth weight cutoff was 
generally 150-200 g lower across gestational weeks 
compared with the commonly cited US national 
reference population. For example, for boys born after 
37 completed gestational weeks, the 10th centile was 
2380 g (Intergrowth) versus 2596 g (US reference 
population).54 Use of the Intergrowth standard 
reduced the numbers of infants classified as small for 
gestational age by a relative 27% overall compared 
with the US 1991 reference, particularly term infants 
weighing ≥2500 g and late preterm (33-37 weeks). 
With a lower birth weight cut off, the Intergrowth 
standard identified a higher risk population.
The co-occurrence of prematurity and small for 
gestational age places infants at substantially, and 
potentially synergistically, higher risk of morbidity 
and neonatal mortality54 compared with their 
counterparts who experience prematurity or small 
for gestational age alone. Each year, an estimated 
1.5 million infants are born both preterm and small 
for gestational age, and these small high risk infants 
are a top priority for public health interventions. The 
estimates related to infants born both preterm and 
small for gestational age were the most affected by 
the choice of growth standard. Prior population birth 
weight references, such as the US reference used in our 
study, have included all pregnancies. In comparison, 
the Intergrowth study excluded pregnancies in women 
with morbidities, meaning that preterm births caused 
by common maternal morbidities in US populations, 
such as obesity and gestational diabetes, were 
removed from the study population. This resulted in 
fewer preterm births and the captured preterm births 
represented a healthier subset. The Intergrowth 
standard had lower 10th centile birth weight cut offs, 
more so for lower gestational ages, thus our estimates 
for small for gestational age among preterm births 
were 47% lower with the Intergrowth standard than 
with the US reference.8
The primary prevention of intrauterine growth 
restriction in low and middle income countries is 
an important intervention target, particularly in 
South Asia, where prevalence is high. The causes 
of intrauterine growth restriction vary by setting. 
While nutritional deficiency is expected to be the 
largest contributor in low and middle income 
countries, there are other causal mechanisms, such 
as maternal infections, placental insufficiency, 
pregnancy morbidity, and environmental exposures 
that contribute in these settings. Further research 
on the country or region specific epidemiology 
and appropriate context specific solutions will be 
necessary to deal with primary prevention effectively. 
A more immediate goal is targeting the coverage and 
quality of interventions to manage morbidities of 
infants born small for gestational age, which will 
also benefit preterm infants. An estimated 80% of 
neonatal deaths occur in infants of small size (small for 
gestational age and/or preterm).41 Small for gestational 
age infants have an increased risk of perinatal 
respiratory depression55 from chronic uteroplacental 
insufficiency56 and postnatal infections from retarded 
development of the immune system.57 Interventions 
such as neonatal resuscitation, management of sepsis, 
chlorhexidine antisepsis of the umbilical cord, and 
early breastfeeding support could successfully target 
the reduction in mortality associated with small for 
gestational age. The effect of kangaroo mother care 
in term infants born small for gestational age also 
deserves further evaluation.
Limitations
The CHERG datasets had several limitations. Several 
of the cohorts were community based studies with 
some missing birth weight data; however, we included 
only datasets with limited amounts of missing data 
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and weight measured within 72 hours of birth, using 
strict a priori inclusion criteria reported elsewhere.8 
Also, data were available only from select countries 
within regions and thus might not be representative 
of the entire region. We therefore used pooled regional 
risk ratios, aiming to increase generalizability of 
the estimations, and national level prevalence and 
mortality rates. Concerted efforts are needed to improve 
the coverage and quality of birth weight data in low and 
middle income countries, particularly in South Asia 
and sub-Saharan Africa, where over half of infants are 
never weighed at birth.58 Another limitation was the 
heterogeneity and quality of measures of gestational 
age. Ultrasound measures were not available in most 
studies, and the remaining studies used date of last 
menstrual period or clinical newborn assessment. 
Three studies, in which date of last menstrual period 
was collected during routine pregnancy surveillance, 
are likely to be more accurate.59 Dating of gestational 
age remains a large obstacle for research and 
programmatic projects in low and middle income 
countries. Accurate and feasible methods of gestational 
age dating will be necessary in the future in these 
countries to improve our epidemiologic understanding 
of the burden of preterm birth and small for gestational 
age. Finally, our analyses only represented the burden 
of SGA among live born babies. Intrauterine growth 
restriction is an important cause of stillbirth, and not 
represented in this analysis.
Conclusions
We estimated that 23.3 million infants (19.3%) were 
born small for gestational age and 606 500 (21.9%) 
neonatal deaths were attributable to small for 
gestational age in low and middle income countries 
in 2012. The largest burden was in South Asia, where 
34% of infants were born small for gestational age and 
289 700 neonatal deaths were attributable to small 
for gestational age. Beyond the neonatal period, small 
for gestational age infants are at increased risk of 
experiencing later morbidity in childhood, including 
poor linear growth and chronic non-communicable 
disease in adulthood, a large yet unquantified burden. 
Overcoming implementation barriers and increasing 
coverage of proved interventions to prevent fetal 
growth restriction and improve survival of small 
infants are key priorities to reduce neonatal mortality 
in low and middle income countries.
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